908 Devices Inc. reports results for the quarter ended September 30 - Earnings Summary
12/11/2024 15:31
* 908 Devices Inc. MASS.OQ reported quarterly adjusted
earnings
of 4 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -22 cents. The mean expectation of
five analysts for the quarter was for a loss of 28 cents per
share. Wall Street expected results to range from -35 cents
to -24 cents per share.
* Revenue rose 17.3% to $16.77 million from a year ago;
analysts
expected $18.33 million.
* 908 Devices Inc.'s reported EPS for the quarter was a loss
of 84
cents.
* The company reported a quarterly loss of $29.3 million.
* 908 Devices Inc. shares had risen by 4.3% this quarter and
lost 67.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "strong buy"
Wall Street's median 12-month price target for 908 Devices Inc.
is $13.00
This summary was machine generated from LSEG data November 12 at
03:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.28 0.04 Beat
Jun. 30 2024 -0.33 -0.31 Beat
Mar. 31 2024 -0.36 -0.33 Beat
Dec. 31 2023 -0.26 -0.23 Beat